Radiomics in Carotid Plaque: A Systematic Review and Radiomics Quality Score Assessment.

Journal: Ultrasound in medicine & biology
PMID:

Abstract

Imaging modalities provide information on plaque morphology and vulnerability; however, they are operator dependent and miss a great deal of microscopic information. Recently, many radiomics models for carotid plaque that identify unstable plaques and predict cardiovascular outcomes have been proposed. This systematic review was aimed at assessing whether radiomics is a reliable and reproducible method for the clinical prediction of carotid plaque. A systematic search was conducted to identify studies published in PubMed and Cochrane library from January 1, 2001, to September 30, 2022. Both retrospective and prospective studies that developed and/or validated machine learning models based on radiomics data to classify or predict carotid plaques were included. The general characteristics of each included study were selected, and the methodological quality of radiomics reports and risk of bias were evaluated using the radiomics quality score (RQS) tool and Quality Assessment of Diagnostic Accuracy Studies-2, respectively. Two investigators independently reviewed each study, and the consensus data were used for analysis. A total of 2429 patients from 16 studies were included. The mean area under the curve of radiomics models for diagnostic or predictive performance of the included studies was 0.88 ± 0.02, with a range of 0.741-0.989. The mean RQS was 9.25 (standard deviation: 6.04), representing 25.7% of the possible maximum value of 36, whereas the lowest point was -2, and the highest score was 22. Radiomics models have revealed additional information on patients with carotid plaque, but with respect to methodological quality, radiomics reports are still in their infancy, and many hurdles need to be overcome.

Authors

  • Chao Hou
    Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
  • Xin-Yao Liu
    Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Yue Du
    Laboratory of Drug Metabolism and Pharmacokinetics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, 110016, PR China.
  • Ling-Gang Cheng
    Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Lu-Ping Liu
    Department of Ultrasound, Lanzhou University Second Hospital, Lanzhou, Gansu Province, China.
  • Fang Nie
    Department of Ultrasound, Lanzhou University Second Hospital, Lanzhou, Gansu 730030, China.
  • Wei Zhang
    The First Affiliated Hospital of Nanchang University, Nanchang, China.
  • Wen He
    Department of Ultrasound, Beijing Tian Tan Hospital, Capital Medical University, Beijing 100070, China.